Development and commercialization of therapeutic drug products that treat rare diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FORWARD GLOBAL |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORWARD GLOBAL | 6 | — |
| Issue | Activities |
|---|---|
| Medical/Disease Research/Clinical Labs | 5 |
| Health Issues | 5 |
| Pharmacy | 5 |